What has 2025 taught us about stem cell innovation and market dynamics? For cell therapy professionals, 2025 was a defining year, not because it produced a single breakthrough, but because it clarified how the future of the sector will actually be built. Instead of chasing headlines, companies focused on solving the structural barriers that have held the field back for more than a decade.
New data, maturing pipelines, and shifting investment patterns brought fresh realism to a sector often driven more by optimism than operational readiness. Above all, 2025 revealed the difference between technologies that promise transformation and infrastructure that can actually deliver it. [Read more…]




